PETACC 3, Randomized phase III trial comparing infused irinotecan/5-fluorouracil (5-FU)/folinic acid (IF) versus 5-FU/FA (F) in stage III colon cancer patients (pts). (PETACC 3) - Van Cutsem, E; Labianca, R; Hossfeld, D (Journal of Clinical Oncology, 2005)
ASCO Annual Meeting Proceedings Abstract LBA8